Aequus Pharmaceuticals Inc Stock Toronto S.E.
Equities
CA0076361033
Pharmaceuticals
Sales 2021 | 2.71M 1.97M | Sales 2022 | 1.38M 1M | Capitalization | 4.64M 3.37M |
---|---|---|---|---|---|
Net income 2021 | -1M -726K | Net income 2022 | -3M -2.18M | EV / Sales 2021 | 5.52 x |
Net cash position 2021 | 256K 186K | Net Debt 2022 | 2.49M 1.81M | EV / Sales 2022 | 5.17 x |
P/E ratio 2021 |
-8.19
x | P/E ratio 2022 |
-1.45
x | Employees | - |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 85.32% |
Managers | Title | Age | Since |
---|---|---|---|
Anne Stevens
FOU | Founder | - | 12-12-31 |
Douglas Janzen
CEO | Chief Executive Officer | 56 | 13-01-02 |
Ann Fehr
DFI | Director of Finance/CFO | 55 | 16-07-21 |
Members of the board | Title | Age | Since |
---|---|---|---|
Douglas Janzen
CEO | Chief Executive Officer | 56 | 13-01-02 |
Marc Lustig
BRD | Director/Board Member | 51 | 21-02-14 |
Director/Board Member | 54 | 14-12-17 |
1st Jan change | Capi. | |
---|---|---|
+33.02% | 704B | |
+28.59% | 577B | |
-3.71% | 348B | |
+18.25% | 327B | |
+4.72% | 288B | |
+14.81% | 234B | |
+4.93% | 198B | |
-9.78% | 194B | |
-4.28% | 147B |